RedShiftBio Lab Photo



RedShiftBio at Biologics UK 2022

March 21, 2022

RedShiftBio will be sponsoring the upcoming Biologics UK Congress, March 21-22, 2022 in London.

This two-day, comprehensive event covers topics including Proteins & Antibodies, Bispecifics in Discovery & Development, and Peptides & Oligonucleotides.

Visit us at Booth #3, where will be exhibiting the AQS³®pro and presenting on applications of Microfluidic Modulation Spectroscopy.

Sponsored Presentation: 

Insights into Predicting Aggregation and Particle Formation Behaviour During Early Formulation Screening: The Role of Microfluidic Modulation Spectroscopy

Rob Forbes, Ph.D. - Professor, University of Central Lancashire, UK / Fujifilm Diosynth Biotechnologies

March 21, 2022 - 11:40am

Aggregation and particle formation are quality attributes that can be impacted by the careful selection of formulation excipients. Predictability of this behaviour from structural information is desirable to the formulator.  The increased measurement sensitivity and reproducibility of Microfluidic Modulation Spectroscopy (MMS) over standard techniques for secondary structure determination is investigated in this case study and utilised to rank potential formulations.  We also highlight how MMS analyzes high concentration moieties in complex backgrounds.

Thank you for submitting the form. A member of our team will reach out shortly.
Oops! Something went wrong while submitting the form.

Request a Demo Today! 

RedShiftBio AQS3 Product Detail